X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
RELIGARE ENT. Announces Quarterly Results (2QFY19); Net Profit Up 57.9%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

RELIGARE ENT. Announces Quarterly Results (2QFY19); Net Profit Up 57.9%
Thu, 29 Nov

RELIGARE ENT. has announced its results for the quarter ended September 2018. Here is a detailed performance review of the same:

RELIGARE ENT. Quarterly Financials

No. of Mths
Qtr. Ending
3
Sep-17*
3
Jun-18*
3
Sep-18*
QoQ ChangeYoY Change
Net SalesRs m271613-20.1%-50.7%
Other incomeRs m15243101135.2%-33.3%
TurnoverRs m1796011592.5%-35.9%
ExpensesRs m408010732.6%168.2%
Gross profitRs m-13-64-94
DepreciationRs m032-14.0%391.1%
InterestRs m443147134-8.9%-69.8%
Profit before taxRs m-305-171-128
TaxRs m0000.0%0.0%
Profit after taxRs m-305-171-128
Gross profit margin%-49.9-391.9-716.2
Effective tax rate%0.00.00.0
Net profit margin%-170.8-286.9-112.1
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 50.7% on a year-on-year (YoY) basis. The expenses were up by 168.2% YoY during the same period.
  • The company's operating profit increased by 606.5% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 716.2% in 2QFY19 as against 49.9% in 2QFY18.
  • Depreciation charges increased by 391.1% and finance costs declined by 69.8% YoY, respectively.
  • Other income declined by 33.3% YoY during the quarter.
  • Net profit for the quarter increased by 57.9% YoY. Net profit margins during the quarter increased from -170.8% in 2QFY18 to -112.1% in 2QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 20.1% on a quarter-on-quarter (QoQ) basis. The expenses were up by 32.6% QoQ during the same period.
  • The company's operating profit declined by 46.0% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 716.2% in 2QFY19 as against 391.9% in 1QFY18.
  • Net profit for the quarter increased by 24.8% QoQ, while net profit margins increased from -285.0% in 1QFY18 to -112.1% in 2QFY19.

To see how RELIGARE ENT. has performed over the last eight quarters, please visit here.

RELIGARE ENT. Share Price Performance

Over the last one year, RELIGARE ENT. share price has moved up from Rs 60.1 to Rs 34.5, registering a Loss of Rs 25.6 or around 42.6%.

Overall, the S&P BSE SENSEX is up 7.1% over the year.

Current Valuations

At the current price of Rs 34.5, the price to book value (P/BV) ratio of RELIGARE ENT. stands at 0.4 times.

Equitymaster requests your view! Post a comment on "RELIGARE ENT. Announces Quarterly Results (2QFY19); Net Profit Up 57.9%". Click here!

  

Related Views on News

RELIGARE ENT. Announces Quarterly Results (3QFY19); Net Profit Up 75.2% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, RELIGARE ENT. has posted a net profit of Rs 103 m (up 75.2% YoY). Sales on the other hand came in at Rs 8 m (down 90.1% YoY). Read on for a complete analysis of RELIGARE ENT.'s quarterly results.

RELIGARE ENT. 2017-18 Annual Report Analysis (Annual Result Update)

Dec 21, 2018 | Updated on Dec 21, 2018

Here's an analysis of the annual report of RELIGARE ENT. for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of RELIGARE ENT.. Also includes updates on the valuation of RELIGARE ENT..

RELIGARE ENT. Announces Quarterly Results (4QFY18); Net Profit Up 27.2% (Quarterly Result Update)

Jun 4, 2018 | Updated on Jun 4, 2018

For the quarter ended March 2018, RELIGARE ENT. has posted a net profit of Rs 643 m (up 27.2% YoY). Sales on the other hand came in at Rs 3 m (down 81.0% YoY). Read on for a complete analysis of RELIGARE ENT.'s quarterly results.

CreditAccess Grameen IPO: Should You Apply to this Interesting Microfinance Play? (IPO)

Aug 7, 2018

Should you apply to the IPO of CreditAccess Grameen Ltd?

HDFC AMC IPO: Do Valuations Leave Enough on Table for Investors? (IPO)

Jul 20, 2018

Should you subscribe to the IPO of HDFC AMC Ltd?

More Views on News

Most Popular

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

3 Stocks to Bet on to Become a 'Dividend Millionaire'(Profit Hunter)

May 14, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

Indian Steel: The Perfect Multibagger Opportunity(Profit Hunter)

May 17, 2019

A structurally strong Indian Steel Industry will help India achieve 8%+ GDP growth in the coming years.

What Makes TVS Srichakra and CCL Products a Cut Above the Rest?(The 5 Minute Wrapup)

May 17, 2019

Despite the commodity nature of their businesses, these two stocks have rewarded shareholders well.

The Bitter Pill that Will Lay the Foundation for Sensex 100,000(The 5 Minute Wrapup)

May 14, 2019

These companies will help the Sensex more than double from current levels.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

RELIGARE ENT. SHARE PRICE


May 24, 2019 (Close)

TRACK RELIGARE ENT.

  • Track your investment in RELIGARE ENT. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

RELIGARE ENT. - REDINGTON COMPARISON

COMPARE RELIGARE ENT. WITH

MARKET STATS